妊娠期糖尿病中的低碳水化合物饮食：营养充足性、血糖控制及围产期结局——基于DiGest试验
Posted inClinical Updates Diabetes & Endocrinology news OB/GYN & Women's Health

Low-Carbohydrate Diets, Nutritional Adequacy, Glycemia, and Perinatal Outcomes in Women With Gestational Diabetes Mellitus: Insights from the DiGest Trial and Contemporary Evidence

This review synthesizes current evidence on low-carbohydrate diets in gestational diabetes mellitus (GDM), highlighting effects on glycemia, nutrient adequacy, and perinatal outcomes from the DiGest trial and supporting literature.
持续葡萄糖监测助力未用胰岛素2型糖尿病血糖管理：CONNECT试验带来新证据
Posted inDiabetes & Endocrinology Internal Medicine news

Enhancing Glycemic Control in Non-Insulin-Treated Type 2 Diabetes with Continuous Glucose Monitoring: New Evidence from the CONNECT Trial

The CONNECT trial demonstrates that continuous glucose monitoring (CGM) significantly improves glycemic control in adults with non-insulin-treated type 2 diabetes managed in primary care, reducing HbA1c levels and hyperglycemia risk without increasing hypoglycemia.
射频消融治疗钙化性乳头状甲状腺微小癌：长期疗效与钙化演变
Posted inDiabetes & Endocrinology news Oncology

Long-Term Outcomes and Calcification Dynamics After Radiofrequency Ablation of Calcified Papillary Thyroid Microcarcinomas

This retrospective study demonstrates that radiofrequency ablation (RFA) effectively treats low-risk papillary thyroid microcarcinomas (PTMC), including those with intratumoral calcifications, with excellent technical success, significant tumor volume reduction, and minimal complications over long-term follow-up.
Orforglipron 在 2 型糖尿病中的心血管安全性和治疗潜力：来自 ACHIEVE-4 3 期试验的发现
Posted inClinical Updates Diabetes & Endocrinology news

Cardiovascular Safety and Therapeutic Potential of Orforglipron Versus Insulin Glargine in Type 2 Diabetes with Elevated Cardiovascular Risk: Insights from the ACHIEVE-4 Phase 3 Trial

A comprehensive review of the ACHIEVE-4 trial confirms orforglipron's cardiovascular safety non-inferior to insulin glargine in type 2 diabetes patients at elevated cardiovascular risk, highlighting its oral administration and safety profile advantages.